A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 25, 2020

Primary Completion Date

July 26, 2021

Study Completion Date

August 6, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

SMP-100

SAD/MAD

DRUG

Placebo

Trial Locations (1)

CMAX Clinical Research Pty Ltd, Adelaide

All Listed Sponsors

lead

Chengdu SciMount Pharmatech Co., Ltd.

INDUSTRY

NCT04296799 - A Phase 1 Study of SMP-100 in Normal Healthy Volunteers | Biotech Hunter | Biotech Hunter